Donate now
Close

Our Scientific Advisory Board

Our scientific advisors provide guidance on our scientific objectives and strategy. They also assist the Foundation by assessing grant proposals that we receive and help us to network with other scientists and industry. They include world leading experts in the field of PHTS, PTEN and associated signalling pathways, with backgrounds in clinical genetics, academic research, the pharmaceutical industry and biomarker development.

Phillip Dennis, MD PhD Image

Phillip Dennis, MD PhD

Vice President Oncology, Lung Cancer, Sanofi Oncology Development, USA

Find out more »
Charis Eng, MD PhD FACP Image

Charis Eng, MD PhD FACP

Hardis Professor and Chair of Genomic Medicine, Cleveland Clinic, USA

Find out more »
Zisis Kozlakidis, PhD AKC MBA FLS Image

Zisis Kozlakidis, PhD AKC MBA FLS

Head of Laboratory Services and Biobanking, International Agency for Research on Cancer, World Health Organisation

Find out more »
Katherine Lachlan, MBChB FRCP Image

Katherine Lachlan, MBChB FRCP

Consultant in Clinical Genetics, University Hospital, Southampton, UK

Find out more »
Donald Ogilvie, MA DPhil Image

Donald Ogilvie, MA DPhil

Independent scientific consultant providing expert advice on cancer drug discovery to academic, industrial, and venture capital organisations

Find out more »
Mustafa Sahin, MD PhD Image

Mustafa Sahin, MD PhD

Professor of Neurology, Harvard Medical School, Boston, USA

Find out more »
Leticia Toledo-Sherman, PhD Image

Leticia Toledo-Sherman, PhD

Vice President of Chemistry, MycRX and Adjunct Assistant Professor of Neurology, UCLA

Find out more »
Philip Vickers, PhD Image

Philip Vickers, PhD

President and Chief Executive Officer at Solu Therapeutics, Boston, USA

Find out more »
Ian Waddell, PhD Image

Ian Waddell, PhD

Chief Scientific Officer, Cumulus Oncology

Find out more »